AerFrame Alignment Laser Box (LBV2)
Stabilix, LLC · Decision date Sep 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-16 for the AerFrame™ Alignment Laser Box (LBV2), submitted by Stabilix, LLC of Dallas, Texas, under 510(k) number K261865. The application was received on 06/04/2026 and reviewed by the Radiology panel under regulation 892.5050, product code IYE, with the device classification name listed as Accelerator, Linear, Medical.
SESE in a 510(k) means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The public record reviewed here does not describe the specific components, design changes, or performance data supporting the comparison, and no summary statement is included. The page lists a traditional review, no third-party review, no combination product status, and no authorized predetermined change control plan.
Clinical indications, patient-selection criteria, and any use parameters are not stated in this record and would need to be confirmed in the underlying FDA submission documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261865
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Stabilix, LLC
- Product code
- IYE
- Decision code
- SESE
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Accelerator, Linear, Medical.
- Applicant
- Stabilix, LLC
- Product code
- IYE
- FDA device class
- 2
FDA decision timeline
K261865 received
Application receipt date recorded by FDA.
K261865 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Stabilix, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Dallas, TX
Sources and methodology
- Original FDA record: K261865
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records